Preclinical and clinical evaluation of safety and efficacy of Pramehakulantaka Rasa in the management of Madhumeha w.s.r. to Diabetes Mellitus TypeII

ational Institute of Ayurveda0 个研究点目标入组 64 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients ready to give concern for the trial & willing to participate in the study for 3 months.
•2.Patients between the age group of 31-70 years in either sex.
•3.Newly diagnosed & confirmed cases of Mahdumeha (Type II Diabetes Mellitus) not talking allopathic drug or Insulin Therapy.
•4.Patients with Fasting Blood Sugar (FBS) in the range of 126mg/dl â?? 250mg/dl or Post Prandial Blood Sugar (PPBS) in the range of 200mg/dl â?? 300 mg/dl and Glycosylated Haemoglobin (HbA1c) 6.5% - 9.0%.
•5.Presence of Cardinal symptoms of Diabetes Mellitus eg. (3P- polyuria, polydipsia, polyphagia).

•1.Patients below 31years of age & above 70 years of age.
•2.Patients having Type I DM.
•3.F.B.S. > 250 mg/dl and P.P.B.S. > 300 mg/dl.
•4.Patients of Type II DM who are on insulin therapy and Drug induced DM.
•5.Patients on allopathic anti-diabetic drug.
•6.DM with complications and Madhumeha with ashadhya upadrava.
•7.Patients having any serious illness like cardiovascular diseases, renal diseases, hepatic diseases, malignancy, any other endocrinopathies etc.
•8.Pregnant and lactating mother.

发起方